Zero debt and an ever increasing patent portfolio. I understand there is over 300m shares in issue. At $3 per share that's close to a $1bn value. At $5 which I understand they are now raising private equity cash at means a $1.5bn valuation.
I'm sorry to say that your clearly don't understand where value comes from in biotech. Like I said to Walhall, are you going to provide any evidence?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.